GlassScriptPhysician profile
Mohammad Altujjar
NPI 1942656087
$2,800.02
in general payments reported to CMS, 2019-2025
20 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $209 · 2023: $291 · 2024: $1,000 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703 · Education: $715 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.41 |
| Education | $714.64 |
| Travel and Lodging | $173.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $763.54 | 2022-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| Boston Scientific Corporation | $528.55 | 2023-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $249.62 | 2025 | |
| Shockwave Medical, INC | $235.99 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Bayer Healthcare Pharmaceuticals INC. | $137.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $128.05 | 2023-2025 | |
| Amgen INC. | $106.72 | 2023-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.75 | 2023 | Lifevest |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $68.88 | 2024-2025 | Opsumit, Uptravi |
| Abiomed | $64.16 | 2024-2025 | Impella |
| Pfizer INC. | $45.28 | 2025 | |
| Janssen Pharmaceuticals, INC | $40.08 | 2023-2024 | Xarelto |
| Terumo Medical Corporation | $33.41 | 2023 | Tr Band, Heartrail, Angio-Seal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29.52 | 2023 | Corevalve Evolut R |
| Altathera Pharmaceuticals LLC | $23.50 | 2024 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2024 | Wainua |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Monitor, Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $14.78 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Altujjar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.